HomeTN8 • ETR
add
Thermo Fisher Scientific Inc
Previous close
€550.40
Day range
€556.60 - €573.50
Year range
€469.65 - €575.60
Market cap
223.49B USD
Avg Volume
200.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 10.60B | 0.23% |
Operating expense | 2.42B | 2.93% |
Net income | 1.63B | -4.96% |
Net profit margin | 15.38 | -5.18% |
Earnings per share | 5.28 | -7.21% |
EBITDA | 2.65B | -6.40% |
Effective tax rate | 5.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.64B | 8.03% |
Total assets | 100.36B | 3.41% |
Total liabilities | 51.26B | -0.64% |
Total equity | 49.10B | — |
Shares outstanding | 382.50M | — |
Price to book | 4.30 | — |
Return on assets | 4.81% | — |
Return on capital | 5.71% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 1.63B | -4.96% |
Cash from operations | 2.17B | -10.27% |
Cash from investing | -3.58B | -202.96% |
Cash from financing | -1.19B | -164.15% |
Net change in cash | -2.43B | -180.50% |
Free cash flow | 1.85B | 16.92% |
About
Founded
1956
Headquarters
Website
Employees
122,000
